What do we know about tailoring treatment with tenofovir?

Pharmacogenomics. 2016 Apr;17(6):531-4. doi: 10.2217/pgs-2016-0003. Epub 2016 Apr 4.
No abstract available

Keywords: HIV; pharmacogenetics; pharmacokinetics; renal; tenofovir; toxicity; tubular.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use*
  • HIV Infections / drug therapy*
  • Humans
  • Tenofovir / adverse effects*
  • Tenofovir / therapeutic use*

Substances

  • Anti-HIV Agents
  • Tenofovir